At close: December 19 at 4:00:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,672.0000
12,801.0000
31,984.0000
64,214.0000
51,775.0000
Investing Cash Flow
-65,206.0000
-12,056.0000
49,925.0000
-76,696.0000
-41,499.0000
Financing Cash Flow
--
--
734.0000
3,550.0000
5,634.0000
End Cash Position
100,777.0000
136,290.0000
135,498.0000
52,590.0000
61,613.0000
Capital Expenditure
-529.0000
-383.0000
-679.0000
-552.0000
-1,795.0000
Free Cash Flow
-18,201.0000
12,418.0000
31,305.0000
63,662.0000
49,980.0000
12/31/2020 - 4/12/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HRTX Heron Therapeutics, Inc.
1.5300
-2.55%
CHRS Coherus BioSciences, Inc.
1.4800
-5.73%
LPCN Lipocine Inc.
4.6800
-1.27%
SAGE Sage Therapeutics, Inc.
5.0000
-0.60%
CNTB Connect Biopharma Holdings Limited
0.9925
+4.25%
ZNTL Zentalis Pharmaceuticals, Inc.
2.9300
+0.51%
SNDX Syndax Pharmaceuticals, Inc.
12.85
-2.95%
PHAT Phathom Pharmaceuticals, Inc.
7.82
-2.13%
VSTM Verastem, Inc.
4.4400
+4.23%
KURA Kura Oncology, Inc.
8.97
-1.64%